USD 3.12
(-11.36%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 162.46 Million USD | -38.7% |
2022 | 232.48 Million USD | 10.82% |
2021 | 209.78 Million USD | 108.95% |
2020 | 100.39 Million USD | 23.34% |
2019 | 81.4 Million USD | 55.47% |
2018 | 52.35 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 27.8 Million USD | -4.82% |
2024 Q1 | 31.54 Million USD | -6.9% |
2024 Q2 | 29.21 Million USD | -7.38% |
2023 Q1 | 44.13 Million USD | -24.63% |
2023 FY | 142.5 Million USD | -38.7% |
2023 Q3 | 41.94 Million USD | -0.57% |
2023 Q2 | 42.18 Million USD | -4.42% |
2023 Q4 | 33.87 Million USD | -19.23% |
2022 Q1 | 57.87 Million USD | 9.52% |
2022 Q2 | 59.02 Million USD | 1.99% |
2022 FY | 232.48 Million USD | 10.82% |
2022 Q4 | 58.55 Million USD | 2.7% |
2022 Q3 | 57.02 Million USD | -3.4% |
2021 Q2 | 44.9 Million USD | -25.36% |
2021 FY | 209.78 Million USD | 108.95% |
2021 Q4 | 52.84 Million USD | 1.89% |
2021 Q3 | 51.86 Million USD | 15.49% |
2021 Q1 | 60.16 Million USD | 94.64% |
2020 Q1 | 23.67 Million USD | -10.66% |
2020 Q4 | 30.91 Million USD | 36.91% |
2020 Q3 | 22.57 Million USD | -2.84% |
2020 Q2 | 23.23 Million USD | -1.85% |
2020 FY | 100.39 Million USD | 23.34% |
2019 FY | 81.4 Million USD | 55.47% |
2019 Q4 | 26.49 Million USD | 0.0% |
2018 FY | 52.35 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott Laboratories | 15.71 Billion USD | 98.966% |
Allurion Technologies Inc. | 120.57 Million USD | -34.743% |
Artivion, Inc. | 223.43 Million USD | 27.287% |
Avanos Medical, Inc. | 375.5 Million USD | 56.733% |
Butterfly Network, Inc. | 162.46 Million USD | 0.0% |
Bio-Rad Laboratories, Inc. | 1.04 Billion USD | 84.491% |
Boston Scientific Corporation | 7.47 Billion USD | 97.827% |
Perspective Therapeutics, Inc. | 17.42 Million USD | -832.32% |
CONMED Corporation | 564.24 Million USD | 71.206% |
Edwards Lifesciences Corporation | 3.09 Billion USD | 94.744% |
Paragon 28, Inc. | 210.1 Million USD | 22.672% |
Glaukos Corporation | 367.83 Million USD | 55.832% |
Globus Medical, Inc. | 887.16 Million USD | 81.687% |
Inspire Medical Systems, Inc. | 568.49 Million USD | 71.422% |
Integer Holdings Corporation | 250.95 Million USD | 35.262% |
Medtronic plc | 16.12 Billion USD | 98.993% |
Nevro Corp. | 389.36 Million USD | 58.274% |
Owlet, Inc. | 51.21 Million USD | -217.199% |
Penumbra, Inc. | 590.87 Million USD | 72.504% |
Vicarious Surgical Inc. | 80.66 Million USD | -101.406% |
Smith & Nephew plc | 3.46 Billion USD | 95.314% |
Sonendo, Inc. | 68.46 Million USD | -137.298% |
STERIS plc | 1.4 Billion USD | 88.398% |
Stryker Corporation | 9.2 Billion USD | 98.236% |
Vapotherm, Inc. | 66.02 Million USD | -146.067% |
Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | 95.041% |